Jawbone out of the consumer fitness tracker business, going to clinical model, raising funds: report

Confirming reports from various sources last year [TTA 21 Dec] and prior (July) is a report in TechCrunch confirming what we already guessed: Jawbone is out of the consumer fitness tracker market, is aiming at a B2B2C market of health providers, and needs to raise a lot more money.

Key points in the article:

  • It intends to market a “health product and accompanying set of services sold primarily to clinicians and health providers working with patients”
  • It’s seeking additional funding from investors. TechCrunch‘s sources claim that is at an advanced stage, but no closings as of yet.

We noted in December that research/analytics company CB Insights calculated that 2015 wearable computing (a broader category that includes smartwatches) investment funding fell 63 percent from 2014 to a level comparable to 2012-13, in large part due to the cooling of the fitness segment. TechCrunch’s end of year report from eMarketer and other sources also noted that 2016 sales growth of the wearables sector, forecast at 60 percent, only achieved 25 percent growth and will be equally weak in 2017. Lack of demand, lack of loyalty (most fitness bands are discarded after 3-6 months), unreliable (TechCrunch makes much of customer displeasure), their looks and generally useless (in a clinical sense) data and the greater versatility (and appearance) of smartwatches for those who want them, are all factors. There’s a disenchantment here (‘who needs ’em?’) that mass marketing can’t overcome.

It is worthwhile reflecting that Jawbone, which started off in 1997 as an audio technology company, has burned through over $980 million in 14 funding rounds, generously provided by various VC luminaries of Silicon Valley. (One wonders how much equity is even left in the company, a la ‘The Producers’) (more…)

Simplifying engagement in diabetes management

[grow_thumb image=”https://telecareaware.com/wp-content/uploads/2014/09/Livongo.jpg” thumb_width=”180″ /]Launched at TechCrunch’s Disrupt SF 2014 was a new wireless glucometer, Livongo Health’s InTouch. A M2M palm-sized cellular glucometer, it transmits not only conventional blood glucose readings from test strips, but also activity information (steps) and how you’re feeling. The user also sets it up for who looks at the data and what they see. Data goes to what they term a ‘smart cloud’ (a/k/a data platform) which reviews it based on clinical rules and accumulated personal health history. It is also backed by a virtual care team of certified diabetes educators. Founder Glen Tullman, who was quoted extensively in our well-read Patients should be less engaged, not more, has an FDA clearance in hand, (more…)